POINT Biopharma Global Inc
NASDAQ:PNT
Income Statement
Earnings Waterfall
POINT Biopharma Global Inc
Revenue
|
243.8m
USD
|
Operating Expenses
|
-136m
USD
|
Operating Income
|
107.8m
USD
|
Other Expenses
|
-11.2m
USD
|
Net Income
|
96.6m
USD
|
Income Statement
POINT Biopharma Global Inc
Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
227
N/A
|
236
+4%
|
241
+2%
|
244
+1%
|
|
Operating Income | |||||||||||
Operating Expenses |
(14)
|
(31)
|
(46)
|
(56)
|
(72)
|
(80)
|
(101)
|
(117)
|
(128)
|
(136)
|
|
Selling, General & Administrative |
(3)
|
(7)
|
(12)
|
(14)
|
(17)
|
(16)
|
(19)
|
(20)
|
(21)
|
(23)
|
|
Research & Development |
(11)
|
(24)
|
(34)
|
(42)
|
(56)
|
(64)
|
(82)
|
(96)
|
(107)
|
(113)
|
|
Operating Income |
(14)
N/A
|
(31)
-118%
|
(46)
-45%
|
(56)
-23%
|
(72)
-29%
|
(80)
-11%
|
126
N/A
|
119
-5%
|
113
-6%
|
108
-4%
|
|
Pre-Tax Income | |||||||||||
Interest Income Expense |
0
|
0
|
(0)
|
0
|
1
|
1
|
4
|
10
|
14
|
19
|
|
Pre-Tax Income |
(14)
N/A
|
(31)
-118%
|
(46)
-45%
|
(56)
-23%
|
(72)
-28%
|
(79)
-9%
|
130
N/A
|
129
0%
|
127
-1%
|
127
0%
|
|
Net Income | |||||||||||
Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(31)
|
(31)
|
(30)
|
(31)
|
|
Income from Continuing Operations |
(15)
|
(32)
|
(46)
|
(57)
|
(72)
|
(79)
|
98
|
98
|
97
|
97
|
|
Net Income (Common) |
(15)
N/A
|
(32)
-117%
|
(46)
-45%
|
(57)
-23%
|
(72)
-28%
|
(79)
-10%
|
98
N/A
|
98
0%
|
97
-1%
|
97
-1%
|
|
EPS (Diluted) |
-0.16
N/A
|
-0.35
-119%
|
-0.62
-77%
|
-0.63
-2%
|
-0.8
-27%
|
-0.87
-9%
|
1.02
N/A
|
0.92
-10%
|
0.92
N/A
|
0.91
-1%
|